|
G |
Anxa5 |
annexin A5 |
increases activity |
ISO |
Sodium Salicylate results in increased activity of ANXA5 protein |
CTD |
PMID:10090950 |
|
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Casp1 |
caspase 1 |
increases activity multiple interactions |
EXP |
Sodium Salicylate results in increased activity of CASP1 protein Sodium Salicylate inhibits the reaction [Paraquat results in decreased activity of CASP1 protein] |
CTD |
PMID:17561093 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases expression |
EXP ISO |
Sodium Salicylate inhibits the reaction [Paraquat results in increased activity of CASP3 protein] Sodium Salicylate results in increased activity of CASP3 protein Sodium Salicylate promotes the reaction [[epothilone A co-treated with Metformin] results in increased expression of CASP3 mRNA]; Sodium Salicylate promotes the reaction [Metformin results in increased expression of CASP3 mRNA] Sodium Salicylate results in increased expression of CASP3 mRNA |
CTD |
PMID:10090950 PMID:17561093 PMID:29117515 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity multiple interactions |
EXP |
Sodium Salicylate results in increased activity of CASP8 protein Sodium Salicylate inhibits the reaction [Paraquat results in increased activity of CASP8 protein] |
CTD |
PMID:17561093 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases activity |
ISO |
Sodium Salicylate results in decreased activity of CDKN1A protein |
CTD |
PMID:15190207 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
Sodium Salicylate promotes the reaction [[EGF protein co-treated with IGF1 protein] results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] |
CTD |
PMID:10993886 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Foxo3 |
forkhead box O3 |
decreases phosphorylation increases expression |
ISO |
Sodium Salicylate results in decreased phosphorylation of FOXO3 protein Sodium Salicylate results in increased expression of FOXO3 protein |
CTD |
PMID:21303813 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Gsn |
gelsolin |
increases cleavage |
ISO |
Sodium Salicylate results in increased cleavage of GSN protein |
CTD |
PMID:10090950 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
Sodium Salicylate results in increased expression of H2AX mRNA |
CTD |
PMID:29117515 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
increases activity |
ISO |
Sodium Salicylate results in increased activity of HSF1 protein |
CTD |
PMID:10328874 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
affects expression |
ISO |
Sodium Salicylate affects the expression of HSPA1B protein |
CTD |
PMID:16184763 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA] |
CTD |
PMID:10328874 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifng |
interferon gamma |
decreases expression |
ISO |
Sodium Salicylate results in decreased expression of IFNG protein |
CTD |
PMID:21303813 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
Sodium Salicylate promotes the reaction [[EGF protein co-treated with IGF1 protein] results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] |
CTD |
PMID:10993886 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
decreases expression multiple interactions |
ISO |
Sodium Salicylate results in decreased expression of IKBKB protein modified form Sodium Salicylate inhibits the reaction [Palmitates results in increased phosphorylation of IKBKB protein] |
CTD |
PMID:21303813 PMID:23504962 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA] |
CTD |
PMID:10328874 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression |
ISO |
Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] Sodium Salicylate results in decreased expression of IL1B mRNA Sodium Salicylate results in decreased expression of IL1B protein |
CTD |
PMID:10328874 PMID:21303813 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
Sodium Salicylate affects the reaction [IL4 results in increased activity of STAT6 protein]; Sodium Salicylate inhibits the reaction [IL4 results in increased phosphorylation of STAT6 protein] |
CTD |
PMID:19767084 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
decreases expression multiple interactions |
ISO |
Sodium Salicylate results in decreased expression of IL6 protein Sodium Salicylate inhibits the reaction [Palmitates results in increased secretion of IL6 protein] |
CTD |
PMID:21303813 PMID:23504962 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
Sodium Salicylate inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased chemical synthesis of Nitric Oxide]]; Sodium Salicylate inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]; Sodium Salicylate inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]] |
CTD |
PMID:23504962 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Irs1 |
insulin receptor substrate 1 |
multiple interactions |
ISO |
Sodium Salicylate inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]]; Sodium Salicylate inhibits the reaction [Palmitates results in increased phosphorylation of IRS1 protein] |
CTD |
PMID:23504962 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions decreases expression |
EXP |
Sodium Salicylate inhibits the reaction [Paraquat results in increased expression of JUN protein] Sodium Salicylate results in decreased expression of JUN protein |
CTD |
PMID:17561093 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP ISO |
Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK1 protein] Sodium Salicylate results in decreased phosphorylation of and results in decreased activity of MAPK1 protein |
CTD |
PMID:10357911 PMID:10993886 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO EXP |
Sodium Salicylate results in decreased phosphorylation of and results in decreased activity of MAPK3 protein Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:10357911 PMID:10993886 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
increases expression |
ISO |
Sodium Salicylate results in increased expression of MCL1 protein |
CTD |
PMID:10090950 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases localization multiple interactions |
EXP ISO |
Sodium Salicylate results in decreased localization of NFKB1 protein Sodium Salicylate inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]] |
CTD |
PMID:9281604 PMID:17259377 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein] |
CTD |
PMID:16936242 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression multiple interactions |
ISO |
Sodium Salicylate results in decreased expression of NOS2 protein [Sodium Salicylate results in decreased expression of NOS2 protein] which results in decreased chemical synthesis of Nitric Oxide |
CTD |
PMID:10860828 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
increases phosphorylation multiple interactions |
ISO |
Sodium Salicylate results in increased phosphorylation of NOS3 protein Sodium Salicylate inhibits the reaction [Palmitates inhibits the reaction [INS protein results in increased phosphorylation of NOS3 protein]] |
CTD |
PMID:21303813 PMID:23504962 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage multiple interactions increases expression |
ISO |
Sodium Salicylate results in increased cleavage of PARP1 protein Sodium Salicylate inhibits the reaction [epothilone A results in increased expression of PARP1 mRNA]; Sodium Salicylate promotes the reaction [Metformin results in increased expression of PARP1 mRNA] Sodium Salicylate results in increased expression of PARP1 mRNA |
CTD |
PMID:9694730 PMID:10090950 PMID:29117515 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pepd |
peptidase D |
decreases activity |
ISO |
Sodium Salicylate results in decreased activity of PEPD protein |
CTD |
PMID:16991207 |
|
NCBI chr 1:87,536,650...87,681,233
Ensembl chr 1:87,536,609...87,681,231
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions decreases activity |
ISO |
Sodium Salicylate results in increased expression of PTGS2 mRNA; Sodium Salicylate results in increased expression of PTGS2 protein 12-HPETE inhibits the reaction [Sodium Salicylate inhibits the reaction [PTGS2 protein results in increased metabolism of Arachidonic Acid]]; 12-HPETE inhibits the reaction [Sodium Salicylate results in decreased activity of PTGS2 protein]; [PTGS2 protein results in increased abundance of prostaglandin G2] inhibits the reaction [Sodium Salicylate inhibits the reaction [PTGS2 protein results in increased metabolism of Arachidonic Acid]]; [PTGS2 protein results in increased abundance of prostaglandin G2] inhibits the reaction [Sodium Salicylate results in decreased activity of PTGS2 protein]; Hydrogen Peroxide affects the reaction [Sodium Salicylate results in decreased activity of PTGS2 protein]; Sodium Salicylate inhibits the reaction [PTGS2 protein results in increased metabolism of Arachidonic Acid] |
CTD |
PMID:12538810 PMID:14742690 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions decreases localization |
ISO EXP |
Sodium Salicylate inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]] Sodium Salicylate results in decreased localization of RELA protein Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased expression of RELA protein]; Sodium Salicylate inhibits the reaction [Palmitates results in increased phosphorylation of RELA protein] |
CTD |
PMID:9281604 PMID:10328874 PMID:17259377 PMID:23504962 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
ISO |
Sodium Salicylate inhibits the reaction [SB 203580 promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]]; Sodium Salicylate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]; Sodium Salicylate promotes the reaction [[EGF protein co-treated with IGF1 protein] results in increased phosphorylation of and results in increased activity of RPS6KB1 protein]; Sodium Salicylate results in decreased phosphorylation of and results in decreased activity of RPS6KB1 protein |
CTD |
PMID:10993886 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
decreases expression increases expression |
ISO |
Sodium Salicylate results in decreased expression of SCARB1 protein Sodium Salicylate results in increased expression of SCARB1 protein |
CTD |
PMID:16816107 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Slc26a5 |
solute carrier family 26 member 5 |
increases expression |
EXP |
Sodium Salicylate results in increased expression of SLC26A5 mRNA; Sodium Salicylate results in increased expression of SLC26A5 protein |
CTD |
PMID:19173110 |
|
NCBI chr 4:13,210,260...13,249,289
Ensembl chr 4:13,210,260...13,249,289
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression |
ISO |
Sodium Salicylate results in increased expression of SOD2 protein |
CTD |
PMID:21303813 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
multiple interactions |
ISO |
Sodium Salicylate affects the reaction [IL4 results in increased activity of STAT6 protein]; Sodium Salicylate inhibits the reaction [IL4 results in increased phosphorylation of STAT6 protein] |
CTD |
PMID:19767084 |
|
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
ISO EXP |
Sodium Salicylate inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]]; Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Sodium Salicylate results in decreased expression of TNF protein Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of TNF protein] Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of TNF protein]; Sodium Salicylate inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Sodium Salicylate inhibits the reaction [Palmitates results in increased secretion of TNF protein] |
CTD |
PMID:9281604 PMID:10328874 PMID:10357911 PMID:17568627 PMID:21303813 PMID:23504962 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
EXP |
Sodium Salicylate inhibits the reaction [Paraquat results in increased expression of TP53 protein] |
CTD |
PMID:17561093 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|